Cover Image
市場調查報告書

學名藥製造工廠計劃:產業趨勢、製造工程、機器、原料、原價收益

Generic Drug Manufacturing Plant Project Report: Industry Trends, Manufacturing Process, Machinery, Raw Materials, Cost and Revenue

出版商 IMARC Services Pvt. Ltd. 商品編碼 344762
出版日期 內容資訊 英文 55 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
學名藥製造工廠計劃:產業趨勢、製造工程、機器、原料、原價收益 Generic Drug Manufacturing Plant Project Report: Industry Trends, Manufacturing Process, Machinery, Raw Materials, Cost and Revenue
出版日期: 2015年11月05日 內容資訊: 英文 55 Pages
簡介

學名藥 (非專利處方藥) ,是接續於新藥 (首發醫藥品) 的醫藥品,在劑量、使用目的、有效性中有兼容性。通常學名藥在新藥的專利失效後銷售。

本報告提供學名藥製造工廠計劃調查分析、建設工廠的技術與商業性藍圖、業績、製造工程必要條件、計劃的經費、資金援助、經濟性等相關驗證等系統性資訊。

第1章 調查手法

第2章 摘要整理

第3章 簡介

第4章 學名藥產業分析

  • 學名藥的分類
  • 市場趨勢
  • 學名藥的價值鏈分析
  • 學名藥製造商主要成功因素
  • 學名藥產業的法規

第5章 學名藥的製造工程

  • 詳細的流程
  • 學名藥製造工廠:原料必要條件

第6章 計劃詳細內容、必要條件、經費

  • 土地、場所、場地平整
  • 工廠設計
  • 工廠機器
  • 原料
  • 包裝
  • 公共事業
  • 人力資源
  • 其他資本投資

第7章 學名藥製造工廠:計劃的經濟性

  • 計劃的資本成本
  • 技術、經濟參數
  • 產品價格
  • 所得預測
  • 支出預測
  • 財務分析

圖表

目錄
Product Code: SRP071531

A generic drug is a pharmaceutical product that can be interchanged with the innovator product and is comparable with it in terms of dosage, intended use and efficacy. Generic drugs are manufactured without a license from the innovator company and are usually marketed after the patent expiry of the innovator drug. The approval process of a generic drug is less time consuming and involves significantly lower costs compared to their branded counterparts. Manufacturers of generic drugs do not require to spend significantly in research and development enabling them to price their products significantly lower than their branded counterparts.

Generics today represent a multibillion dollar industry. One of their biggest drivers is an increasing global pharmaceutical spending trend towards generics. Continuously increasing healthcare expenditures have pushed governments and third-party payers to seek ways to control their healthcare expenditures. This is catalyzing an increasing demand for generics versus their branded counterparts. Another major driver of this industry is the continued patent cliff that is providing growing pipeline opportunities for generic firms. Similarly, a growth in the overall global population and aging demographics is also proving to be beneficial for the overall healthcare sector including generic drug manufacturers. Healthcare reforms in the US and other developed markets coupled with strong growth in emerging market are some other important drivers for the industry.

IMARC's latest study “Generic Drug Manufacturing Plant Project Report: Industry Trends, Manufacturing Process, Machinery, Raw Materials, Cost and Revenue” provides a techno-commercial roadmap for setting up a generic drug manufacturing plant. The study, which has been done by one of the world's leading research and advisory firms, covers all the requisite aspects of the generic drug manufacturing plant. This ranges from macro overview of the market to micro details of the industry performance, manufacturing requirements, project cost, project funding, project economics, expected returns on investment, profit margins, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who are planning to foray into the generic drug industry in any manner.

Key Questions Answered in This Report?

  • What are the key success and risk factors in the generic industry?
  • How has the generic market performed so far and how will it perform in the coming years?
  • What is the structure of the generic industry and who are the key players?
  • What are the various unit operations involved in a generic drug manufacturing plant?
  • What is the total size of land required for setting up a generic drug manufacturing plant?
  • What are the machinery requirements for setting up a generic drug manufacturing plant?
  • What are the raw material requirements for setting up a generic drug manufacturing plant?
  • What are the utility requirements for setting up a generic drug manufacturing plant?
  • What are the manpower requirements for setting up a generic drug manufacturing plant?
  • What are the infrastructure costs for setting up a generic drug manufacturing plant?
  • What are the capital costs for setting up a generic drug manufacturing plant?
  • What are the operating costs for setting up a generic drug manufacturing plant?
  • What should be the pricing mechanism of generic drugs?
  • What will be the income and expenditures for a generic drug manufacturing plant?
  • What is the time required to break-even?

Table of Contents

1. Research Methodology

2. Executive Summary

3. Introduction

4. Global Generic Drug Industry Analysis

  • 4.1. Classification of Generic Drugs
  • 4.2. Market Trends
    • 4.2.1. Current, Historical and Future Market Trends
    • 4.2.2. Market Breakup by Region
    • 4.2.3. Competitive Structure and Major Players in the Generic Drug Industry
    • 4.2.4. Market Forecast
  • 4.3. Value Chain Analysis of Generic Drugs
  • 4.4. Key Success Factors for Generic Manufacturers
  • 4.6. Regulations in the Generic Industry

5. Manufacturing Process of Generic Drugs

  • 5.1. Detailed Process Flow
  • 5.2. Generic Drugs Manufacturing Plant: Raw Material Requirements

6. Project Details, Requirements and Costs Involved

  • 6.1. Land, Location and Site Development
  • 6.2. Plant Layout
  • 6.3. Plant Machinery
  • 6.4. Machinery Pictures
  • 6.5. Raw Materials
  • 6.6. Packaging
  • 6.7. Utilities
  • 6.8. Manpower
  • 6.9. Other Capital Investments

7. Generic Drug Manufacturing Plant: Project Economics

  • 7.1. Capital Cost of the Project
  • 7.2. Loans and Financial Assistance
  • 7.3. Techno-Economic Parameters
  • 7.4. Product Pricing
  • 7.5. Income Projections
  • 7.6. Expenditure Projections
  • 7.7. Financial Analysis

List of Figures

  • Figure 4-1: Global: Generic Drug Market: Sales Value (in US$ Billion), 2010-2014
  • Figure 4-2: Global: Generic Drug Market: Breakup by Country (in %), 2014
  • Figure 4-3: Global: Generic Drug Market Forecast: Sales Value (in US$ Billion), 2015-2020
  • Figure 4-4: Global: Generic Drug Market: Value Chain
  • Figure 6-1: Generic Drug Manufacturing: Detailed Process Flow and Various Types of Unit Operations Involved
  • Figure 6-2: Generic Drug Manufacturing Process: Conversion Rate of Feedstocks
  • Figure 7-1: Generic Drug Manufacturing Plant: Proposed Plant Layout
  • Figure 7-2: Generic Drug Manufacturing Plant: Primary Packaging
  • Figure 7-3: Generic Drug Manufacturing Plant: Secondary Packaging
  • Figure 7-4: Generic Drug Manufacturing Plant: Tertiary Packaging
  • Figure 8-1: Generic Drug Manufacturing Plant: Breakup of Capital Costs (in %)
  • Figure 8-2: Generic Drug Manufacturing Plant: Breakup of Production Costs (in %)

List of Tables

  • Table 4-1: Global: Generic Drug Market: Revenues of Key Players (in US$ Billion), 2014
  • Table 7-1: Generic Drug Manufacturing Plant: Costs Related to Land and Site Development (in US$)
  • Table 7-2: Generic Drug Manufacturing Plant: Costs Related to Civil Works (in US$)
  • Table 7-3: Generic Drug Manufacturing Plant: Machinery Costs (in US$)
  • Table 7-4: Generic Drug Manufacturing Plant: Raw Material Requirements (in Kg/Day)
  • Table 7-5: Generic Drug Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
  • Table 7-6: Generic Drug Manufacturing Plant: Costs Related to Other Capital Investments
  • Table 8-1: Generic Drug Manufacturing Plant: Capital Costs (in US$)
  • Table 8-2: Details of Financial Assistance Offered by Financial Institutions
  • Table 8-3: Generic Drug Manufacturing Plant: Loan Installments
  • Table 8-4: Generic Drug Manufacturing Plant: Techno- Economic Parameters
  • Table 8-5: Generic Drug Manufacturing Plant: Income Projections (in US$)
  • Table 8-6: Generic Drug Manufacturing Plant: Expenditure Projections (in US$)
  • Table 8-7: Generic Drug Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability
  • Table 8-8: Generic Drug Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability
Back to Top